Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
tirzepatide is a dual agonist (GIP/GLP-1) Peak weight loss : Retatrutide showed 28.7% at 68 weeks (Phase 3 TRIUMPH-4) and 24.2% at 48 weeks (Phase 2) vs tirzepatide 20.9% (Phase 3) Liver fat : Retatrutide's glucagon agonism provides pronounced hepatic fat reduction (up to 82%) Regulatory status : Tirzepatide is FDA-approved
CJC-1295/Ipamorelin protocols typically dose 100300 mcg of each compound subcutaneously before bed, producing peak GH elevation 3060 minutes post-injection with return to baseline within 34 hours
These are 1000 mcg, given once a month
At Modern Medicine, you can address these deficiencies effectively with safe, medically supervised B12 and B-Well injections tailored to your health needs
US$ 28.79
US$ 29.77
US$ 21.97
US$ 22.44
US$ 28.83
US$ 24.42
